Little incentive from pharmaceutical legislation to promote alternatives to animal testing

donderdag 13 augustus 2015 15:00

Current pharmaceutical legislation does not impose any legal constraints on the use of alternatives to animal testing, but neither does it actively encourage the use of these alternatives. Alternative methods are permitted, but it must be demonstrated that these have the same predictive value as animal testing. In practice, the required validation procedure is often complicated, costly and time-consuming. These are the findings of research conducted by The Dutch National Institute for Public Health and the Environment (RIVM).